Humana shares tumble as 2025 membership for its top-rated Medicare plans slump

(Reuters) -Humana said on Wednesday that a lower-performance rating for a widely used Medicare insurance plan hurt enrollments for 2025 and will potentially hit the health insurer’s revenue and bonus payments in 2026, sending shares down about 23% premarket. The company said it has about 1.6 million, or 25% of its total members, currently enrolled…

Read More

OpenAI closes $6.6 billion funding haul at valuation of $157 billion with investment from Microsoft and Nvidia

By Krystal Hu (Reuters) – OpenAI has raised $6.6 billion from investors at a post-money valuation of $157 billion, cementing the ChatGPT maker’s status as one of the most valuable private companies in the world,sources familiar with the matter said on Wednesday. The funding has attracted returning venture capital investors including Thrive Capital and Khosla…

Read More

Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug

(Reuters) – Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene. U.S. District Judge Jesse Furman in Manhattan said UMB Bank was never properly appointed trustee for shareholders owning…

Read More

Tesla’s quarterly deliveries set to rise as China incentives lure wary EV buyers

By Akash Sriram and Abhirup Roy (Reuters) – Tesla is expected to report an 8% jump in third-quarter deliveries of its electric vehicles on Wednesday, Wall Street estimates show, driven by extended incentives and lucrative financing plans in the world’s largest auto market, China. Responding to sluggish Chinese spending amid flagging economic growth and rising…

Read More